ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

139 hedge funds and large institutions have $755M invested in Intra-Cellular Therapies Inc. in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 26 reducing their positions, and 25 closing their positions.

Holders
139
Holders Change
+6
Holders Change %
+4.51%
% of All Funds
3.07%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
33
Increased
64
Reduced
26
Closed
25
Calls
$10.9M
Puts
$7.69M
Net Calls
+$3.19M
Net Calls Change
+$292M
Name Market Value Shares Shares
Change
Shares
Change %
Creative Planning
151
Creative Planning
Kansas
-9,300 Closed
Arrowstreet Capital
152
Arrowstreet Capital
Massachusetts
-8,700 Closed
Ameriprise
153
Ameriprise
Minnesota
-8,386 Closed
Principal Financial Group
154
Principal Financial Group
Iowa
-8,054 Closed
AB
155
Amalgamated Bank
New York
-8,009 Closed
Janney Montgomery Scott
156
Janney Montgomery Scott
Pennsylvania
-6,787 Closed
JSMC
157
Jess S. Morgan & Co
California
-6,500 Closed
Rafferty Asset Management
158
Rafferty Asset Management
New York
-6,476 Closed
PP
159
PDT Partners
New York
-6,229 Closed
FANJ
160
Financial Architects (New Jersey)
New Jersey
-5,000 Closed
VCP
161
Verus Capital Partners
Arizona
-3,000 Closed
AIM
162
Aigen Investment Management
New York
-1,199 Closed
SCM
163
Sio Capital Management
New York
CM
164
Caption Management
Oklahoma
HT
165
HAP Trading
New York
Verition Fund Management
166
Verition Fund Management
Connecticut
Group One Trading
167
Group One Trading
Illinois
CFGS
168
Concourse Financial Group Securities
Alabama
SSG
169
Summit Securities Group
New York
BCM
170
Bluefin Capital Management
New York
CAC
171
Cowen and Company
New York
PA
172
Perceptive Advisors
New York
AT
173
Arden Trust
Delaware
$0 14 +14 New
VCM
174
Versant Capital Management
Arizona
$0 14 +14 New